Save the date for the 8th annual Emerging Therapies conference for blood cancer patients and caregivers! Local experts from Stanford University School of Medicine and University of California, San Francisco will present the latest research advances shared at the American Society of Hematology (ASH®) Annual Meeting. Last year’s attendees expressed an interest in learning more about the economics of cancer and we are pleased to announce that this year’s keynote speaker is Jamie A. Ledezma, an attorney from the Cancer Legal Resource Center.
Emerging Therapies is a free program, but space is limited and registration is required. Individuals interested in attending, can register online or call us at 866.450.0669.
2012 Emerging Therapies for Blood Cancer Patients
Saturday, January 21, 2012
9:00 a.m. – 12:30 p.m.
San Francisco Marriott Marquis (New Location)
55 Fourth Street San Francisco, CA 94103
9:00 a.m. Arrival and Breakfast Served
9:30 a.m. Keynote Address
The Economics of Cancer: Jamie A. Ledezma, Esq.
Staff Attorney, Cancer Legal Resource Center
10:30 a.m. Concurrent Breakout Sessions
Chronic Lymphoid Leukemia: Steven Coutré, M.D.
Associate Professor of Medicine, Division of Hematology, Stanford University School of Medicine
Chronic Myeloid Leukemia: Neil Shah, M.D., Ph.D.
Assistant Professor, Division of Hematology/Oncology, University of California, San Francisco School of Medicine
Non-Hodgkin Lymphoma (High Grade/Aggressive): Weiyun Ai, M.D., Ph.D.
Clinical Professor of Medicine; Division of Hematology/Oncology, University of California, San Francisco
Non-Hodgkin Lymphoma (Low Grade/Indolent): C. Babis Andreadis, M.D., MSCE
Assistant Clinical Professor of Medicine, Adult Bone Marrow Transplantation Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Multiple Myeloma: Thomas Martin, M.D.
Professor of Medicine and Associate Director of the Myeloma Institute, University of California, San Francisco
Myelodysplastic Syndromes: Jason Gotlib, M.D.
Assistant Professor of Medicine, Division of Hematology, Stanford University School of Medicine
The 2012 Northern California Emerging Therapies conference is made possible by the generosity of our partners and sponsors.
2012 Partners: Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Oncology Center, Stanford Cancer Center, and University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
2012 Sponsors: Celgene, Sanofi and Millennium
ASH® is a registered trademark of the American Society of Hematology. This conference is not sponsored, sanctioned, or part of the 53rd Annual Meeting of the American Society of Hematology.